On the public citation graph
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience
0 signed · 52 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/acr.23426openalex-snapshot
Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
inferredcites →https://doi.org/10.1002/art.41456openalex-snapshot
COVID‐19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease‐Modifying Antirheumatic Drugs on Clinical Outcomes
inferredcites →https://doi.org/10.1002/jmv.25685openalex-snapshot
Coronavirus infections and immune responses
inferredcites →https://doi.org/10.1007/s10067-009-1286-9openalex-snapshot
Non-Hodgkin’s lymphoma in systemic sclerosis: case and literature review
inferredcites →https://doi.org/10.1007/s10067-020-05189-yopenalex-snapshot
COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
inferredcites →https://doi.org/10.1016/j.coviro.2012.04.004openalex-snapshot
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
inferredcites →https://doi.org/10.1016/j.dsx.2020.04.020openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
inferredcites →https://doi.org/10.1016/j.jinf.2020.03.019openalex-snapshot
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
inferredcites →https://doi.org/10.1016/j.jmii.2020.03.005openalex-snapshot
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
inferredcites →https://doi.org/10.1016/j.jpha.2020.03.001openalex-snapshot
Molecular immune pathogenesis and diagnosis of COVID-19
inferredcites →https://doi.org/10.1016/j.virusres.2007.02.007openalex-snapshot
Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway
inferredcites →https://doi.org/10.1016/s0140-6736(20)30304-4openalex-snapshot
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
inferredcites →https://doi.org/10.1016/s0140-6736(20)30558-4openalex-snapshot
Comorbidities and multi-organ injuries in the treatment of COVID-19
inferredcites →https://doi.org/10.1016/s0140-6736(20)30566-3openalex-snapshot
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
inferredcites →https://doi.org/10.1016/s0140-6736(20)30628-0openalex-snapshot
COVID-19: consider cytokine storm syndromes and immunosuppression
inferredcites →https://doi.org/10.1016/s1473-3099(20)30132-8openalex-snapshot
COVID-19: combining antiviral and anti-inflammatory treatments
inferredcites →https://doi.org/10.1021/acscentsci.0c00272openalex-snapshot
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
inferredcites →https://doi.org/10.1038/cr.2012.165openalex-snapshot
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
inferredcites →https://doi.org/10.1038/ncomms4594openalex-snapshot
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
inferredcites →https://doi.org/10.1038/s41584-020-00562-2openalex-snapshot
Rheumatic disease and COVID-19: epidemiology and outcomes
inferredcites →https://doi.org/10.1093/cid/ciaa248openalex-snapshot
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
inferredcites →https://doi.org/10.1093/rheumatology/keq242openalex-snapshot
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
inferredcites →https://doi.org/10.1093/rheumatology/kes305openalex-snapshot
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
inferredcites →https://doi.org/10.1101/2020.02.10.20021832openalex-snapshot
Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)
inferredcites →https://doi.org/10.1128/mmbr.05015-11openalex-snapshot
Into the Eye of the Cytokine Storm
inferredcites →https://doi.org/10.1136/annrheumdis-2013-204223openalex-snapshot
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
inferredcites →https://doi.org/10.1136/annrheumdis-2013-204575openalex-snapshot
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
inferredcites →https://doi.org/10.1136/annrheumdis-2019-216653openalex-snapshot
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
inferredcites →https://doi.org/10.1136/annrheumdis-2020-217424openalex-snapshot
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
inferredcites →https://doi.org/10.1136/annrheumdis-2020-217871openalex-snapshot
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
inferredcites →https://doi.org/10.1136/annrheumdis-2020-218694openalex-snapshot
To immunosuppress: whom, when and how? That is the question with COVID-19
inferredcites →https://doi.org/10.1136/annrheumdis-2020-eular.949openalex-snapshot
FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS
inferredcites →https://doi.org/10.1136/ard.2006.057265openalex-snapshot
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis
inferredcites →https://doi.org/10.31138/mjr.31.3.259openalex-snapshot
Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
inferredcites →https://doi.org/10.3390/pathogens9030231openalex-snapshot
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
inferredcites →https://doi.org/10.4414/smw.2016.14290openalex-snapshot
Comorbidity in rheumatoid arthritis
inferredcites →https://doi.org/10.55563/clinexprheumatol/r3k9l6openalex-snapshot
COVID-19: the new challenge for rheumatologists
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.71.e124471zenodo-depositor-declared
Application of biological medicinal products and tyrosine kinase inhibitors in rheumatoid arthritis and COVID-19: A systematic review of scientific literature
inferred← citeshttps://doi.org/10.1002/ccr3.5233openalex-snapshot
Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with ankylosing spondylitis during the coronavirus disease (COVID‐19) pandemic: A case series
inferred← citeshttps://doi.org/10.1007/s00296-021-04902-7openalex-snapshot
COVID-19 in patients with gout on colchicine
inferred← citeshttps://doi.org/10.1007/s40744-021-00342-8openalex-snapshot
TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study
inferred← citeshttps://doi.org/10.1007/s40744-022-00425-0openalex-snapshot
Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
inferred← citeshttps://doi.org/10.1016/j.ejim.2022.05.014openalex-snapshot
Treatment strategies of COVID-19: A rheumatology perspective
inferred← citeshttps://doi.org/10.1111/apt.16717openalex-snapshot
Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments
inferred← citeshttps://doi.org/10.18203/2320-6012.ijrms20231645openalex-snapshot
Rheumatoid arthritis, multiple sclerosis and lupus: key points from the COVID-19 era
inferred← citeshttps://doi.org/10.22038/abjs.2022.60064.2959openalex-snapshot
Effects of Biologic Therapies on the Chance of COVID-19 Infection Among Rheumatoid Arthritis and Lupus Patients During the First Wave of the Pandemic.
inferred← citeshttps://doi.org/10.22541/au.168000851.19570523/v1openalex-snapshot
Effect of anti-rheumatic drugs on the clinical outcome of autoimmune rheumatic diseases patients infected with COVID-19: A systemic review and meta-analysis
inferred← citeshttps://doi.org/10.31138/mjr.33.1.68openalex-snapshot
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
inferred← citeshttps://doi.org/10.3390/md20040257openalex-snapshot
One-Step Preparative Separation of Fucoxanthin from Three Edible Brown Algae by Elution-Extrusion Countercurrent Chromatography
inferred← citeshttps://doi.org/10.46497/archrheumatol.2024.10313openalex-snapshot
Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients
inferred← citeshttps://doi.org/10.5114/reum.2022.119039openalex-snapshot
Influence of biologic and conventional disease-modifying antirheumatic drugs on COVID-19 incidence among rheumatic patients during the first and second wave of the pandemic in Iran
inferred← citeshttps://doi.org/10.7759/cureus.60128openalex-snapshot
Impact of COVID-19 Pandemic on Patients With Rheumatic Diseases in Medina, Saudi Arabia: An Observational Cross-Sectional Study
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.